Understanding Your Treatment Transition Options
Can You Switch From Wegovy To Mounjaro: Complete Dose Availability
When considering whether you can switch from Wegovy to Mounjaro, having access to all doses is crucial for a smooth transition. EverydayMeds stocks every strength of both medications, from the initial 0.25mg starter dose through to the 2.4mg maintenance level. This comprehensive availability means patients never need to source different doses from multiple pharmacies, ensuring continuity of care throughout their weight management journey.
The decision to switch from Wegovy (semaglutide) to Mounjaro (tirzepatide) involves several clinical considerations that our prescribers can discuss with you. Wegovy works as a GLP-1 receptor agonist, whilst Mounjaro functions as a dual GIP and GLP-1 receptor agonist. Both are prescription-only medicines that require clinical assessment and ongoing monitoring to ensure safe, effective treatment alongside lifestyle modifications.
Pricing Structure for Switching From Wegovy to Mounjaro
Understanding the cost implications when you switch from Wegovy to Mounjaro helps with treatment planning. At EverydayMeds, Wegovy single pens range from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance strength. Our Getting Started Bundles, such as the Intro Duo (0.25mg & 0.5mg) at £169.99, provide excellent value for those beginning their transition journey. New customers can apply code FIRST40 at checkout, whilst returning patients use DOSE25 to reach these competitive prices.
For patients considering the switch from Wegovy to Mounjaro, our bundle options offer practical advantages beyond cost savings. The Progress Trio (0.5mg, 1mg & 1.7mg) at £369.99 covers three crucial escalation steps, whilst our Consistency bundles provide extended supply of the same dose during transition periods. This pricing structure supports both gradual dose adjustments and extended treatment continuity without pharmacy changes.
Clinical Evidence Behind Switching from Wegovy to Mounjaro
When patients ask "can you switch from Wegovy to Mounjaro", the clinical evidence base provides important context. The STEP trials demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021). Mounjaro's SURMOUNT trials showed different outcomes, though direct comparisons aren't appropriate due to varying trial designs and patient populations.
Both medications work through appetite regulation mechanisms, but their receptor targeting differs significantly. This distinction may influence why some patients and prescribers consider switching from Wegovy to Mounjaro during treatment. Clinical assessment helps determine the most appropriate medication choice based on individual response patterns, side effect profiles, and treatment goals.
How Wegovy Works When Considering Mounjaro Switch
Understanding Wegovy's mechanism helps inform decisions about switching from Wegovy to Mounjaro. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone GLP-1, which is released after eating to signal fullness to the brain. This medication works by slowing gastric emptying, reducing appetite, and promoting satiety after smaller meals. The once-weekly injection targets specific brain centres involved in appetite regulation, potentially reducing food cravings throughout the week. These mechanisms support weight management when combined with a reduced-calorie diet and increased physical activity. The consistent weekly dosing schedule provides steady hormone levels, which many patients find convenient for long-term treatment adherence.
Ordering Process for Wegovy to Mounjaro Transitions
The process for patients wanting to switch from Wegovy to Mounjaro begins with our comprehensive 3-minute online clinical assessment. This assessment captures your current treatment history, response to Wegovy, and reasons for considering Mounjaro, ensuring our prescribers have complete information for safe transition planning. Following assessment submission, our clinical team reviews your case within 3 working days (or 24 hours with express service), considering factors like current dose, treatment duration, and any side effects experienced. Once approved, your medication ships via next-day cold-chain delivery with temperature monitoring throughout transit. Our GPhC-registered pharmacy (#9012878) maintains strict temperature controls to preserve medication integrity during delivery.
Storage Considerations When Switching Wegovy to Mounjaro
Storage requirements present practical differences when you switch from Wegovy to Mounjaro that patients should understand. Wegovy requires refrigeration at 2-8°C before first use but offers superior travel flexibility with 6 weeks at room temperature (below 30°C) once removed from the fridge. The FlexTouch pen delivery system provides consistent dose accuracy throughout the escalation schedule from 0.25mg through 2.4mg maintenance. Dose escalation follows a mandatory 4-week schedule at each strength, and patients cannot skip doses during the titration period. This systematic approach helps minimise side effects whilst building therapeutic effectiveness. Understanding these storage and dosing requirements helps patients maintain treatment continuity during any transition period.
Seamless Transition Support for Wegovy to Mounjaro Switch
EverydayMeds specialises in supporting patients who need to switch from Wegovy to Mounjaro without treatment interruption. Our comprehensive stock levels mean both medications remain available throughout your transition timeline, eliminating supply concerns during critical treatment periods. The clinical team provides detailed transition guidance, helping coordinate timing between your final Wegovy dose and initial Mounjaro administration.
This specialised transition support extends beyond simple medication supply to include ongoing monitoring and adjustment recommendations. Patients switching from Wegovy to Mounjaro benefit from our complete dose range availability, ensuring appropriate starting strengths and escalation paths remain accessible. Our system tracks treatment history across both medications, providing prescribers with comprehensive data for optimised transition planning and long-term treatment success.
Complete Treatment Continuity for Wegovy-Mounjaro Switches
For patients ready to switch from Wegovy to Mounjaro, EverydayMeds provides unparalleled treatment continuity through our complete inventory and clinical expertise. Visit https://everydaymeds.co.uk/collections/wegovy to explore our full range of treatment options and bundle configurations designed for seamless transitions. New customers can apply code FIRST40 at checkout, whilst returning patients use DOSE25 for competitive pricing across all available strengths. Our clinical team stands ready to support your treatment journey with comprehensive assessments, ongoing monitoring, and expert guidance throughout any medication transitions. With next-day delivery, complete dose availability, and GPhC registration (#9012878), we ensure your weight management goals remain achievable regardless of which medication best suits your needs. Remember that switching from Wegovy to Mounjaro requires clinical supervision and should always be undertaken with professional medical guidance.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
